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Several Novel Nuclear Envelope
Transmembrane Proteins Identified in Skeletal
Muscle Have Cytoskeletal Associations*□S
Gavin S. Wilkie‡§, Nadia Korfali‡§, Selene K. Swanson¶, Poonam Malik‡,
Vlastimil Srsen‡, Dzmitry G. Batrakou‡**, Jose de las Heras‡, Nikolaj Zuleger‡,
Alastair R. W. Kerr‡, Laurence Florens¶, and Eric C. Schirmer‡ ‡‡
Nuclear envelopes from liver and a neuroblastoma cell line
have previously been analyzed by proteomics; however,
most diseases associated with the nuclear envelope affect
muscle. To determine whether muscle has unique nuclear
envelope proteins, rat skeletal muscle nuclear envelopes
were prepared and analyzed by multidimensional protein
identification technology. Many novel muscle-specific pro-
teins were identified that did not appear in previous nuclear
envelope data sets. Nuclear envelope residence was con-
firmed for 11 of these by expression of fusion proteins and
by antibody staining of muscle tissue cryosections. More-
over, transcript levels for several of the newly identified
nuclear envelope transmembrane proteins increased dur-
ing muscle differentiation using mouse and human in vitro
model systems. Some of these proteins trackedwithmicro-
tubules at the nuclear surface in interphase cells and accu-
mulated at the base of the microtubule spindle in mitotic
cells, suggesting they may associate with complexes that
connect the nucleus to the cytoskeleton. The finding of
tissue-specific proteins in the skeletal muscle nuclear en-
velope proteome argues the importance of analyzing nu-
clear envelopes from all tissues linked to disease and sug-
gests that general investigation of tissue differences
in organellar proteomes might yield critical insights.
Molecular & Cellular Proteomics 10: 10.1074/mcp.
M110.003129, 1–16, 2011.
The nuclear envelope (NE)1 is an impenetrable membrane
barrier between the nucleus and the cytoplasm perforated by
nuclear pore complexes (NPCs) that regulate transport of solu-
ble macromolecules in and out of the nucleus (1, 2). Structurally,
the NE consists of the outer nuclear membrane (ONM) that is
continuous with the endoplasmic reticulum (ER) (3), a lumen, the
inner nuclear membrane (INM), and associated proteins includ-
ing the NPCs and the intermediate filament nuclear Lamin poly-
mer (4). Both the ONM and the INM have unique sets of trans-
membrane proteins, sometimes called NETs for nuclear
envelope transmembrane proteins. Lamins and several NETs
have been linked to an increasing number of relatively rare
diseases that range from forms of muscular dystrophy to neu-
ropathy, dermopathy, lipodystrophy, bone disorders, and ac-
celerated aging syndromes (5, 6).
The three favored molecular mechanisms to explain NE dis-
ease pathology are mechanical instability from disruption of
Lamin-cytoskeleton interactions, altered expression of genes
regulated from the nuclear periphery, and disabling of the cell
cycle/stem cell maintenance (6, 7). All of these may involve
additional associated proteins to produce pathology. Indeed, it
would seem that some proteins must be missing from the
system as those so far mutated in disease are widely ex-
pressed, yet each disease exhibits pathology in a particular
subset of the tissues in which the protein is expressed. Because
both gene regulation and cytoskeletal connections have been
implicated, NE proteins involved could reside in either the INM
or the ONM.
The mechanical stability of the NE is derived largely from
the nuclear Lamin polymer. Loss of Lamins (8–10) or their
mutation (11) greatly disturbs nuclear morphology and sta-
bility. This stability itself varies among different cell types as,
for example, neutrophils have highly lobulated nuclei and
have higher relative concentrations of the Lamin B2 subtype
(12), which is the least stable of the different Lamin sub-
types (13, 14). In contrast, muscle cells must withstand high
shear forces and have high concentrations of Lamin A, the
most stable subtype. Many NETs bind Lamins, some of
which also make connections across the lumen of the NE to
From the ‡Wellcome Trust Centre for Cell Biology, University of
Edinburgh, Edinburgh EH9 3JR, United Kingdom and ¶Stowers Insti-
tute for Medical Research, Kansas City, Missouri 64110
Received, July 13, 2010, and in revised form, September 14, 2010
Author’s Choice—Final version full access.
Published, MCP Papers in Press, September 27, 2010, DOI
10.1074/mcp.M110.003129
1 The abbreviations used are: NE, nuclear envelope; NET, nuclear
envelope transmembrane protein; INM, inner nuclear membrane; SR,
sarcoplasmic reticulum; ONM, outer nuclear membrane; MudPIT,
multidimensional protein identification technology; NPC, nuclear pore
complex; ER, endoplasmic reticulum; EDMD, Emery-Dreifuss muscu-
lar dystrophy; qRT-PCR, quantitative RT-PCR; FDR, false discovery
rate; NSAF, normalized spectral abundance factor; dNSAF, distrib-
uted normalized spectral abundance factor; CKM, creatine muscle
kinase; MYOG, myogenin; MYH1, myosin heavy chain 1; Hs, homo
sapiens; Mm, mus musculus.
Research
Author’s Choice © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.
This paper is available on line at http://www.mcponline.org
Molecular & Cellular Proteomics 10.1 10.1074/mcp.M110.003129–1
ONM proteins (15), which in turn connect the NE to the
cytoskeleton (16, 17).
Mutations in the LMNA gene encoding Lamins A and C
cause forms of Emery-Dreifuss muscular dystrophy (EDMD)
(18, 19), limb-girdle muscular dystrophy (LGMD-1B) (20), and
dilated cardiomyopathy with conduction defect (CMD1A) (21),
which each affect different muscle groups, although all are
often also associated with cardiac conduction defects. Muta-
tions in the transmembrane proteins Emerin and Nesprin 1
cause other forms of EDMD (22, 23). Nesprins have been
shown to connect to cytoskeletal proteins (16, 17, 24, 25).
Thus, both Lamins and NETs involved in connecting Lamins
to the cytoskeleton can cause muscle disease in humans.
Postulating that other, more muscle-specific proteins might
also contribute to NE-cytoskeleton interactions, we sought to
determine whether additional NETs could be found in the NE
proteome of skeletal muscle. The previously validated sub-
tractive approach was applied (26) using microsomes/sarco-
plasmic reticulum (SR) and mitochondria, the principal mem-
brane contaminants expected, as subtractive fractions. Many
new NE proteins were identified that had not been identified in
previous NE proteomics investigations using liver, blood, and
neuroblastoma cells (26–28). NE residence was confirmed for
11 novel NETs by expression of epitope-tagged versions and
using antibodies on tissue cryosections.
Muscle-specific expression was determined for several
NETs both according to transcriptome databases (29) and by
direct testing with qRT-PCR. Moreover, some of the novel
skeletal muscle NETs were up-regulated in myogenesis. Ex-
pression of NETs as tagged fusions revealed that NETs
TMEM214 and KLHL31 concentrate at the nuclear surface
with partial overlap with microtubules, suggesting some con-
nectivity with the cytoskeleton. Moreover, TMEM214 and the
NET WFS1 have a unique distribution at the base of the
spindle poles in mitosis similar to that recently reported for
NET5/TMEM201/Samp1 (30). Thus, some of these newly
identified muscle NETs could potentially contribute to cy-
toskeletal defects in NE muscle diseases.
EXPERIMENTAL PROCEDURES
Preparation of Skeletal Muscle NEs and Microsomes/SR—Six to 10
week-old Sprague-Dawley rats were obtained from the University of
Edinburgh animal facility according to university ethics procedures.
For time and gradient size constraints, each individual preparation
was limited to six rats. The procedure is given with full details in Ref.
31, but briefly, hind leg muscle between the femur and hip was
isolated after discarding the sciatic nerve, and the muscle was
crudely chopped into roughly 0.5-cm pieces, rinsed, and weighed.
This was minced three times at 4 °C in 50 ml of ice-cold homogeni-
zation buffer (10 mM HEPES, pH 7.4, 60 mM KCl, 0.5 mM spermidine,
0.15 mM spermine, 2 mM EDTA, 0.5 mM EGTA, and 300 mM sucrose
with freshly added protease inhibitors and 2 mM DTT) and then
brought to a volume of 5 ml/g of starting muscle mass with homog-
enization buffer. A Potter-Elvehjem motorized Dounce homogenizer
with a 0.1–0.15-mm-clearance Teflon pestle was used at 900–1000
rpm to produce a crude homogenate that was then poured through
four layers of sterile cheesecloth on ice in a 4 °C room. Crude nuclei
were pelleted from the filtrate at 1000  g in a swinging bucket rotor
for 10 min at 4 °C. The supernatant was carefully removed and
processed for mitochondria and microsome/SR membranes (see be-
low). The crude nuclear pellet was washed with Percoll gradient buffer
(10 mM HEPES, pH 7.4, 60 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, and
300 mM sucrose), repelleted, and resuspended in 26.7 ml of ice-cold
Percoll gradient buffer. Percoll (Sigma 77237) was added to a final
concentration of 27% (v/v), and nuclei were pelleted at 27,000 g for
30 min at 4 °C in a swinging bucket rotor. Some fragmented myofi-
brils have a mass similar to that of nuclei but a different density, so the
isopycnic gradient accumulates them at the top (32). Nuclei were
collected from where they banded near the bottom of the tube.
Fractions were checked for nuclear enrichment by microscopy. The
nuclear fraction was diluted 10-fold with ice-cold SHKM buffer (50 mM
HEPES, pH 7.4, 25 mM KCl, 5 mM MgCl2, 1 mM DTT, and 0.25 M
sucrose) and pelleted by centrifugation at 4000  g for 20 min at 4 °C
in a swinging bucket rotor. This pellet still contains other membrane
and cytoplasmic contaminants, so the pellets were resuspended in 11
ml of ice-cold SHKM buffer using a hand-held Dounce homogenizer.
39 ml of SHKM buffer with 2.3 M sucrose was added to bring the
sucrose concentration to 1.85 M. 25 ml was removed to each SW28
ultracentrifuge tube and underlaid with 5 ml of ice-cold SHKM buffer
with 2.15 M sucrose and then a further 5 ml of SHKM buffer with
2.8 M sucrose using a 14-gauge needle. After centrifugation in an
SW28 swinging bucket rotor for 60 min at 82,000  g at 4 °C, the
nuclei occur at the interface of the 2.8 and 2.15 M sucrose layers.
Nuclei were collected, diluted 10-fold in SHKM buffer, centrifuged at
4000  g for 20 min at 4 °C, and then resuspended in SHKM buffer,
and nuclei were counted using a hemocytometer. At this stage, no
contaminants could be observed under the microscope.
NEs were then prepared from isolated nuclei by two rounds of
digestion with DNase I (Sigma D4527) and RNase A (Sigma R4875) in
0.3 M sucrose, 10 mM HEPES, pH 7.4, 2 mMMgCl2, 0.5 mM CaCl2, and
2 mM DTT (using a Dounce homogenizer to resuspend nuclei) for 20
min followed by layering onto the same buffer with 0.9 M sucrose and
centrifugation at 4000  g for 10 min at 4 °C to wash out and float
digested chromatin. The first round used nuclei at 1–2 million/ml with
10 units/ml DNase and 1.4 mg/ml RNase, and the second round used
nuclei at 2–4 million/ml with 50 units/ml DNase and 5 mg/ml RNase.
Digestions were followed by rapid staining of nuclei with 4,6-dia-
midino-2-phenylindole dihydrochloride (DAPI) using a fluorescence
microscope and extended if most of the DAPI signal had not been
washed out. NEs were snap frozen in liquid nitrogen and maintained
at 80 °C.
To prepare mitochondria and microsomes enriched in SR mem-
branes, 0.5 mM EDTA was added to the postnuclear supernatant to
inhibit metalloproteases. This homogenate was first centrifuged at
10,000  g at 4 °C for 20 min to pellet mitochondria. The postmito-
chondrial supernatant was then subjected to centrifugation at
100,000  g for 45 min at 4 °C to generate a crude microsomal/SR
pellet. This was resuspended in 5 ml of ice-cold SHKM buffer, and the
sucrose concentration was increased to 2 M by adding 2.7 volumes of
ice-cold 2.8 M SHKM buffer. 28 ml of these membranes was added to
SW28 ultracentrifuge tubes and overlaid with 7 ml of ice-cold SHKM
buffer with 1.85 M sucrose and again with 3 ml of regular SHKM
buffer. Microsomes were floated at 57,000  g for 4 h at 4 °C in an
SW28 swinging bucket rotor. Microsomes were recovered by aspira-
tion of material at the interphase between the 1.85 M sucrose layer
and the uppermost 0.25 M sucrose layer, diluted with 4 volumes of
SHKM buffer, and pelleted at 152,000  g in a 45 Ti rotor for 75 min.
NE preparations were accumulated and divided into aliquots. One
aliquot was extracted on ice with 400 mM NaCl, 25 mM HEPES, pH
8.0, 5 mM MgCl2, 10 mM DTT, and 1% -D-octyl glucoside. A separate
NE aliquot and a microsomal membrane aliquot were extracted with
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0.1 N NaOH and 10 mM DTT. The material used for mass spectrometry
was pelleted from the extracted material by centrifugation at
150,000  g for 30 min and washed three times in filtered H2O prior
to digestion.
MudPIT—Two biological replicate preparations of NaOH-extracted
NEs and SR were analyzed in duplicate, whereas two technical rep-
licates were obtained for one preparation of salt- and detergent-
extracted NEs (Table I and supplemental Table S1). Pellets were
solubilized in 0.1 M Tris-HCl, pH 8.5, 8 M urea, and 5 mM tris(2-
carboxylethyl)phosphine hydrochloride. Next, free cysteines were al-
kylated with 10 mM iodoacetamide for 30 min, and Endoproteinase
Lys-C (Roche Applied Science) was added at a 1:100 (w/w) enzyme to
protein ratio for 6 h at 37 °C. Urea was diluted to 2 M with 0.1 M
Tris-HCl, pH 8.5, and CaCl2 (0.5 mM) and modified Trypsin (1:100,
w/w) were added for 12 h at 37 °C. Digestions were quenched with
5% formic acid (33). Samples were centrifuged for 30 min at 17,500
g. Supernatants (Ti Table 1) were directly analyzed by MudPIT,
whereas pellets were further resuspended in 0.1 M sodium carbonate
(Na2CO3), pH 11.5, 8 M urea, and 5 mM tris(2-carboxylethyl)phosphine
hydrochloride for 30 min; incubated with 10 mM iodoacetamide for 30
min; and then further digested with Proteinase K for 4 h at 37 °C and
separately analyzed by MudPIT (34).
MudPIT was performed as described previously (35) using a
200–300 nl/min flow rate over 12–15 cycles (Table I and
supplemental Table S1) of 120 min each of increasing salt concen-
trations followed by organic gradients (5–80% acetonitrile with 0.1%
formic acid) (35). The last two to five chromatography steps consisted
of a high salt wash with 5% acetonitrile, 0.1% formic acid, and 500
mM ammonium acetate followed by the acetonitrile gradient. Distal
application of a 2.5-kV voltage electrosprayed eluting peptides di-
rectly into a linear ion trap mass spectrometer (ThermoFinnigan).
Each full MS scan (from 400 to 1600m/z) was followed by five MS/MS
events using data-dependent acquisition (at 35% collision energy).
The raw mass spectrometric data may be downloaded from
proteomecommons.org Tranche using the hash identifiers provided in
Table I and supplemental Table S1.
RAW files extracted into ms2 file format (36) using RAW_Xtract
v.1.0 (37) were queried for peptide sequence information using SE-
QUEST v.27 (revision 9) (38) against 28,400 rat proteins (non-redun-
dant NCBI sequences on July 10, 2006) plus 197 human and mouse
homologs of previously identified NETs (26) and 172 sequences from
usual contaminants (e.g. human keratins). To estimate false discovery
rates, each non-redundant protein entry was randomized and added
to the database, bringing the total search space to 57,538 sequences
(supplemental Table S1). MS/MS spectra were searched without
specifying differential modifications, but 57 Da were added stati-
cally to cysteine residues to account for carboxamidomethylation. No
enzyme specificity was imposed during searches, setting a mass
tolerance of 3 amu for precursor ions and of 0.5 amu for fragment
ions.
Different runs were compared using DTASelect and Contrast (39).
Spectrum/peptide matches were retained if at least 7 amino acids
long with ends complying with proteolytic specificity. Other criterion
were Cn  0.08; XCorr  1.8 for singly, 2.0 for doubly, and 3.0 for
triply charged spectra; and a maximum Sp rank of 10. For Proteinase
K-digested samples, no specific peptide ends were imposed, but the
Cn cutoff was increased to 0.15 (40), whereas XCorr minima were
increased to 2.5 for doubly and 3.5 for triply charged spectra
(SEQUEST parameters for the spectrum to peptide matches for all
detected proteins are provided in supplemental Table S2). Peptide
hits were merged from all analyses to establish a master list of
proteins identified by at least two peptides or one peptide with two
independent spectra. In addition, six previously described liver
and blood NETs as well as three newly characterized skeletal
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muscle NETs were manually selected although detected by single
peptides (annotated spectra for these proteins are provided in
supplemental Fig. S1). Based on the merged detected peptides,
proteins could fall into three categories following the parsimony prin-
ciple. (i) Proteins detected by the exact same set of peptides were
grouped together because they could not be distinguished based on
the available peptide data (see column named “Proteins in Group” in
supplemental Table S3), and only one arbitrarily selected represent-
ative protein entry is reported for such groups of proteins (see column
labeled “Locus” in supplemental Table S3). (ii) Proteins with at least
one peptide uniquely mapping to them were considered unique en-
tries. (iii) Subset proteins for which no unique peptides were detected
were removed from the final list of identified proteins.
Identifications mapping to shuffled peptides were used to estimate
false discovery rates. Spectral FDR was calculated as shown in
Equation 1.
Spectral FDR
2 SHUFFLED_SpectralCounts
Total_SpectralCounts
 100
(Eq. 1)
Protein level FDR was calculated as shown in Equation 2.
Protein FDR
SHUFFLED_Proteins
Total_Proteins
 100 (Eq. 2)
Under these criteria, the final FDRs at the protein and peptide levels
were on average 2.2  0.9 and 0.3  0.09%, respectively
(supplemental Table S3).
Normalized spectral counts (NSAF) were calculated for each non-
redundant protein to estimate relative protein levels as described
(41–43).
NSAFi
SpectralCount/Lengthi

k1
N
SpectralCount/Lengthk
(Eq. 3)
To refine spectral counts to deal with peptides shared between
multiple proteins (44), dNSAFs were calculated based on distrib-
uted spectral counts for each run in which shared spectral counts
were distributed based on spectral counts unique to each isoform
(supplemental Table S3). For each protein, averaged dNSAF and
standard deviations (supplemental Table S3) were calculated
across several replicate analyses of NE and SR samples
(supplemental Table S1).
Bioinformatics Analysis—Proteins were mapped to an Ensembl
gene to remove redundancy from differences in protein annotations
and cross-referenced to the human genes with Ensembl release 48
(45). Orthologous group identities were sorted according to frequency
of detection in the NE and microsome runs, relative levels (determined
by averaged dNSAF values), membrane helix prediction (determined
using TMHMM 2.0; http://www.cbs.dtu.dk/services/TMHMM-2.0/;
Ref. 46), and dNSAF ratios between values measured in NEs versus
microsomes/SR (supplemental Table S3). Biologically interesting
gene ontology terms were retrieved from the mySQL database (http://
amigo.geneontology.org; Ref. 47) and added to tables. Comparison
of expression levels in different tissues was done by downloading
relative values from BioGPS (http://biogps.gnf.org/#gotowelcome;
Refs. 29 and 48) and calculating the -fold expression over the median
value from a wide variety of mouse tissues tested in this transcrip-
tome database.
Plasmid Construction—IMAGE clones for human NETs TMEM38A,
TMEM194, POPDC2, KLHL31, WFS1, TMEM70, MBOAT5, CKAP4,
TMEM214, RHBDD1, and TMEM201 were obtained from RZPD and
Geneservice. Coding sequences were amplified by PCR with added
5	 and 3	 restriction sites, sequenced from both ends in intermediate
cloning vectors, and then inserted into mammalian expression vector
pEGFP-N2 (Clontech) or pmRFP-N2 (derived from pEGFP-N2 by
replacing the GFP coding sequence with that of monomeric red
fluorescent protein). Sec61-GFP was obtained from Tom Rapoport
(Harvard, Boston, MA).
Antibodies and Western Blotting—Antibodies used were glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) (Enogene E1C604),
Calreticulin (Cell Signaling Technology 2891S), Calnexin (Stressgen
SPA-860), Lamin A (3262; Ref. 11), Nup153 (Covance MMS-102P),
Nup358 (raised against recombinant human protein amino acids
2595–2881; a kind gift from F. Melchior), SUN2 (Millipore 06-1038),
Tubulin (Sigma T6074), TMEM38A (Millipore 06-1005), POPDC2 (Mil-
lipore 06-1007), TMEM201 (Millipore 06-1013), and LOC203547 (Mil-
lipore 06-1008). All fluorophore-conjugated secondary antibodies
were minimally cross reactive from donkey (Jackson ImmunoRe-
search Laboratories) or goat (Molecular Probes).
Mitochondria prepared as described above were directly lysed in
sample buffer. Muscle NE and microsomes/SR were incubated on ice
in 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM MgCl2, and 0.2%
Nonidet P-40 with protease inhibitors; then heated at 65 °C for 2 min;
and sonicated in a 4 °C sonic bath. Protein concentrations were
determined by Bradford assay before adding sample buffer. Mito-
chondrial loading was based on Coomassie staining compared with
NE and SR lanes.
All blots shown were run according to standard procedures, and
protein bands were visualized and quantified with IR800-conjugated
secondary antibodies using a LI-COR Odyssey imaging system and
software (Odyssey 3.0.16) using median background subtraction. For
Fig. 2, example blots are shown, whereas for Fig. 5, a graph from
averages of three independent blots for each NET and controls is
presented.
Cell Culture, Differentiation, and Transient Transfection—HT1080,
HeLa, U2OS, RD, and C2C12 cells were maintained in high glucose
DMEM (4.5 g/liter glucose; Invitrogen) supplemented with 10% fetal
bovine serum (FBS), 100 g/l penicillin, and 100 g/l streptomycin
sulfate (Invitrogen). RD and C2C12 cells were differentiated after 2
days of confluence by replacing the medium with 0.2% FBS medium
containing 10 g/ml 12-O-tetradecanoylphorbol-13-acetate and
0.1% FBS medium containing 5 g/ml insulin and 5 g/ml transferrin,
respectively. Successful differentiation into myotubes was confirmed
by light microscopy, counting that more than half of cell bodies
exhibited the lengthening characteristic of myotubes and were
multinucleate. Cells were extracted for RNA typically 2–3 days after
myotubes became prevalent. Adherent cells destined for microscopy
were plated on coverslips, and when indicated, DNA was transfected
the next day using FuGENE 6 (Roche Applied Science) according to
the manufacturer’s instructions.
Immunofluorescence Microscopy—After 30 h post-transfection,
cells were directly fixed for 7 min in 3.7% formaldehyde and pro-
cessed for microscopy after permeabilization for 6 min in 0.2% Triton
X-100. For the prefixation extractions in Fig. 5, cells were first washed
with PBS; then extracted for 1 min with 1% Triton X-100, 25 mM Tris,
pH 8.0, 150 mM KOAc, 15 mM NaCl, and 5 mM MgCl2; washed again
with PBS; and then fixed with formaldehyde. In both cases, cells were
then blocked with 10% FBS and 200 mM glycine in PBS and incu-
bated for 40 min at RT with relevant antibodies. DNA was visualized
with Hoechst 33342 or DAPI, and coverslips were mounted in Flu-
oromount-G (EM Sciences). Most images were obtained using a
Nikon TE-2000 microscope equipped with a 1.45 numerical aperture
100 objective, PIFOC Z-axis focus drive (Physik Instruments), Sedat
quad filter set, and CoolSnapHQ High Speed Monochrome charge-
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coupled device camera (Photometrics). Those in Fig. 4A were decon-
volved from 0.2-m sections using AutoquantX. Structured illumina-
tion images in Fig. 4Bwere taken on the OMX system at the University
of Dundee microscopy facility, and Alexa Fluor secondary antibodies
(Molecular Probes) were used (other details are available upon
request).
For cryosections, fresh rat heart or leg muscle was cut into 2–3-mm
cubes, embedded in optimal cutting temperature compound (Tissue-
Tek), snap frozen in liquid nitrogen, and maintained at 80 °C. Sec-
tions were cut on a Leica CM 1900 cryostat at 6–8-m thickness and
fixed in 20 °C methanol. After rehydration, sections were incubated
with NET antibodies overnight at 4 °C followed by secondary anti-
bodies as above. Cryosection images were recorded using an SP5
confocal system (Leica) with 63 oil 1.4 numerical aperture objective
using argon and UV lasers. Micrographs were saved from source
programs as .tif files and prepared for figures using Photoshop 8.0.
Electron Microscopy—Isolated skeletal muscle NEs were fixed in
3% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.3, for 2 h;
washed in 0.1 M sodium cacodylate; postfixed in 1% osmium tetrox-
ide for 45 min; washed again; and dehydrated in 50, 70, 90, and 100%
normal grade acetones for 10 min each and then for a further two
10-min changes in analar acetone. Samples were then embedded in
Araldite resin. 60-nm-thick sections were cut on a Reichert OMU4
ultramicrotome (Leica), stained in uranyl acetate and lead citrate, and
then viewed in a Phillips CM120 transmission electron microscope.
Images were taken at 100 kV at 11,000 magnification using a Gatan
Orius charge-coupled device camera.
Semiquantitative and Quantitative RT-PCR—For differentiation ex-
periments, cells were lysed with TRI Reagent (Sigma), and total RNA
was extracted according to the manufacturer’s instructions from
C2C12 or RD myoblasts or 4-day differentiated myotubes. RT-PCRs
were carried out with 100 ng of total RNA using the Titan one-tube
RT-PCR system (Roche Applied Science) in accordance with the
manufacturer’s instructions except that the dNTP concentration was
increased to 500 M and MgCl2 was increased to 3 mM. Typical
reaction conditions were 30 min of reverse transcription at 50 °C; 2
min of denaturation at 94 °C; and then 24 cycles of 94 °C for 30 s,
60 °C for 30 s, and 68 °C for 45 s. Peptidylprolyl isomerase A (PPIA)
was used as a loading control, and creatine muscle kinase (CKM),
myogenin (MYOG), and myosin heavy chain 1 (MYH1) were used as
positive controls. Human (Hs) and mouse (Mm) primer sets used are
given in supplemental Table S4.
For tissue expression experiments, human tissue RNAs were pur-
chased from Stratagene except for blood RNA that was prepared
from peripheral blood mononuclear cells isolated from buffy coats
obtained from the Scottish National Blood Transfusion Service. 8 g
of RNA from each tissue was first converted into cDNA using a First
Strand cDNA Synthesis kit (Thermoscript, Invitrogen) using a mixture
of reverse primers for the cDNA to be amplified at a final concentra-
tion of 3 M. The quantitative real time RT-PCR control was CKM in
heart muscle. Standard curves were performed using a Roche Light-
cycler for each primer pair by serial dilutions of cDNA products of
heart muscle (1:5, 1:25, 1:125, and 1:625) to estimate PCR efficiency.
GAPDH was used as the internal control to normalize the cDNA
samples across the different tissues, and the relative abundance of
each mRNA within the tissues was calculated using heart as the
standard reference dilution. To avoid amplification of contaminating
genomic DNA, primers from each set were specific to different exons.
Primers used are given in supplemental Table S4.
RESULTS
Generation of Muscle NE Fractions—Rat leg muscle nuclei
were prepared using a method that first depleted collagen
from crude lysates (confirmed by Western blot; data not
shown), thus presumably removing most connective tissue
and enriching for myofiber nuclei. Myofibrillar material and
contaminating membranes were then removed on Percoll and
sucrose gradients (31) (Fig. 1, A and B). Isolated nuclei were
subsequently digested with DNase and RNase and salt-
washed to remove most of the nuclear contents (Fig. 1C).
Even after such isolation, NEs maintain strong connections to
various protein partners including a fraction of peripheral
chromatin as shown by electron microscopy (Fig. 1D). There-
fore, to further purify NEs prior to mass spectrometry analysis,
NE fractions were extracted with 1% -octyl glucoside and
400 mM NaCl or with 0.1 N NaOH (Fig. 1A), which enrich for
proteins associated with the insoluble intermediate filament
Lamin polymer and integral membrane proteins, respectively.
Both extracted fractions were separately analyzed (sup-
plemental Table S1) because previous NE proteome analyses
demonstrated that some well characterized NETs are distrib-
uted to one or the other fraction (26, 27).
Microsomes enriched in SR were separately prepared as a
comparative/subtractive fraction. Some SR would be ex-
pected to contaminate NEs because the ONM is continuous
with the SR, and also during nuclear isolation, some SR
vesicles may stick to the surface of nuclei. In contrast, as
nuclei are stable and pellet fully at low speeds, there should
be no NE contamination in the microsome/SR fraction. In-
deed, neither Lamins A/C nor the NET LAP2, used as NE
markers, were observed in the SR fraction by Western blot
analysis (Fig. 2, A and B). Therefore, as the only membrane in
the nucleus is the NE, all membrane proteins enriched in the
NE fractions compared with the SR fractions should be true
NETs. As expected, there were similar levels of the SR protein
Calnexin in NE fractions because half of the NE, the ONM, is
continuous with the SR (Fig. 2B). Mitochondria are also ex-
pected to stick to NEs during isolation, although most should
in theory be removed by Dounce homogenization and sucrose
gradients that float many contaminating membranes (Fig. 1A).
Indeed, just as the NE Lamin A/C proteins were undetectable
in a separately prepared mitochondrial fraction, the mitochon-
drial protein Porin was not detectable in the crude NE fraction
(Fig. 2C).
As the vast majority of material was lost in isolating clean
NEs from the skeletal muscle, NEs isolated from at least 15
separate preparations were combined prior to alkali or salt/
detergent extraction. Thus, variation between preparations
should have been averaged out.
MudPIT Analysis—After extraction, pellets of isolated NE
fractions were digested with Endoproteinase Lys-C and Tryp-
sin. Because somemembrane proteins that associate with the
intermediate filament Lamin polymer resist extraction with 2%
Triton X-100 and 2 M NaCl, and the polymer itself is not
completely solubilized even in 8 M urea, a second digestion
was performed on material that remained insoluble after the
Endoproteinase Lys-C and Trypsin digestion. Thus, material
that could be pelleted at 17,500  g for 30 min was subse-
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quently digested with Proteinase K at high pH (34). The results
of each digestion and replicates can be compared in sup-
plemental Table S3. Five separate MudPIT runs were per-
formed for NaOH-extracted NEs (one with Proteinase K
digestion), and two were performed for the salt/detergent-
extracted NEs. Six MudPIT runs were performed on the SR
material extracted with NaOH (two with Proteinase K diges-
tion). Thus, using different extraction conditions and different
digestions and performing multiple runs were expected to
provide comprehensive coverage to identify all proteins in the
FIG. 1. Cellular fractionation of rat muscle. A, method schematic.
Nuclei were first prepared from diced and homogenized rat leg mus-
cle and cleaned of contaminating cellular structures by centrifugation
first on isopycnic gradients and then on sucrose to float contaminat-
ing membranes while pelleting the denser nuclei. Crude NEs were
prepared by digesting/extracting nuclear contents from isolated nu-
clei. Before MudPIT analysis, these were further extracted with 1%
-octyl glucoside and 400 mM NaCl or with 0.1 N NaOH to enrich for
proteins associated with the insoluble Lamin polymer and integral
membrane proteins, respectively. Microsomes/sarcoplasmic reticu-
lum preparations were generated separately and analyzed for com-
parison/subtraction as they contain most expected membrane con-
taminants of the NE. B, top panel, before running both gradients, the
crude nuclear fractions contained many chunks of myofibrillar mate-
rial (e.g. Z-bands; highlighted with white arrowheads) released during
homogenization. Bottom panels, after both gradients, isolated nuclei
were clean of these contaminants. Phase-contrast light microscope
images are shown. Scale bar, 10 m. C, enrichment for NEs by
chromatin digestion. DAPI staining for DNA visualizes significant nu-
clear chromatin content in an isolated muscle nucleus (left panels) and
the loss of most of this material after two rounds of digestion with
DNase and RNase each followed by salt washes (two right panels).
Fluorescence microscope images are shown. Scale bar, 5 m. D,
ultrastructure of isolated NEs. Electron micrographs of crude muscle
NEs show that most material in the population has the characteristic
double membrane structure of the NE with little contamination from
single membrane vesicles (a likely SR single membrane vesicle con-
taminant is highlighted by the white arrowhead). Arrows point to
positions of NPCs. These NEs were further salt/detergent- or alkali-
extracted prior to analysis by MudPIT. After such treatment, no struc-
ture remains that can be readily discerned by EM with the character-
istics of NEs. Scale bar, 0.2 m.
FIG. 2. Fraction purity. A, Coomassie-stained gel of NE and mi-
crosome/SR muscle fractions analyzed and also of a separately iso-
lated muscle mitochondrial fraction (Mito). B, the SR marker Calnexin
was present in both the SR and NE fractions because the ONM is
continuous with the SR and shares many proteins. In contrast, the SR
fraction was completely free of NE-specific markers, the NET LAP2
and Lamins A/C. Loading was the same as for A with similar amounts
of total protein loaded. C, the mitochondrial marker Porin was absent
from NEs, whereas Lamins A/C were absent from mitochondria.
Loading was the same as in A and B.
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skeletal muscle NE. A total of seven MudPIT runs were
acquired on the NE fractions because we postulated that
some tissue-specific NETs might not be highly abundant. To
test this, the frequency of NET detection of the seven NE runs
was plotted against an estimate of abundance based on
normalized spectral counts (dNSAF) (42, 44). A clear relation-
ship was observed with the more abundant NETs tending to
be detected not only in multiple analyses of the same tissue
but also in independent analyses of different tissues
(supplemental Fig. S2).
After removing redundancy by converting protein iden-
tities to orthologous gene groups, 1267 proteins were
identified in total for the skeletal muscle NE data sets
(supplemental Table S3). Separately, 1408 proteins were
identified in the SR data sets (supplemental Table S3). Al-
though fractions appeared to be clean of mitochondria by
Western blot analysis, to more fully test mitochondrial con-
tamination, data sets were compared with lists of mitochon-
drial proteins from a previous mass spectrometry study of that
organelle (49) (supplemental Table S3). After subtracting 74
proteins that were previously identified in mitochondria, 1193
proteins remained in the skeletal muscle NE fraction. Using
microsomes/SR strictly as an absolute subtractive fraction
would have resulted in the loss of several well characterized
FIG. 3. NET tissue specificity of ex-
pression. A, expression data were down-
loaded from the BioGPS transcriptome
database that compared over 60 mouse
tissues on microarrays. The median ex-
pression value was obtained over the
complete set of tissues, and data for a
subset of tissues are graphed relative to
this median value. Of the novel muscle
putative NETs represented on the arrays,
only one was not expressed notably
above the median value in either heart or
skeletal muscle (LPCAT3) with six ex-
pressed more than 100-fold over the me-
dian. In many cases, the median value
occurred at background levels of expres-
sion (see Table II), so NETs that tended to
be expressed around the median in most
tissues besides muscle are more uniquely
expressed in muscle. Error bars are
standard deviations from fluorescence
values from multiple microarrays. B,
quantitative real time PCR of the same
NETs and the control CKM over a smaller
set of tissues. The values were generated
in relation to GAPDH expression in the
same reactions, and each NET is graphed
as the -fold expression over its levels in
liver. Tissue-preferential expression was
also observed for several NETs directly
tested by qRT-PCR; however, expression
was sometimes observed in tissues that
were at background levels according to
the transcriptome data. Of particular
note, LPCAT3, the only NET that was not
up-regulated in skeletal muscle or heart
according to transcriptome data, was
up-regulated in skeletal muscle more
than 5-fold by qRT-PCR. The expression
of these new muscle NETs in blood and
liver was at low/background levels by
both methods, consistent with their hav-
ing been uniquely identified in the skel-
etal muscle NE. Error bars are standard
deviations from 3 Q-RT PCR replicates.
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NETs including LBR, Emerin, SUN2, and Nesprin 1 (50–54).
To some degree this is expected; for example, Emerin is not
unique to the INM, and separate functions have been reported
in the ONM, ER, and interstitial discs (55–57). Furthermore, a
recent proteomics study suggests that at least a third of all
proteins have multiple cellular localizations (58). Nonetheless,
the number of spectra recovered from NEs was much greater
than for ER for all the previously characterized NETs. Adding
spectra from all runs, LBR had only two spectra recovered
from the SR fraction compared with 94 from the NE fraction,
Emerin had one in the SR compared with 33 in the NE fraction,
SUN2 had 24 in the SR compared with 1490 in the NE, and
Nesprin 1 had two in the SR compared with 281 in the NE
(supplemental Table S3). Thus, instead of absolute subtrac-
tion, proteins were ordered according to their dNSAF estimate
of abundance (42, 44), and NE data sets were restricted to
those proteins either not detected in the microsomes or at
least 5 more abundant than in the microsome fractions
based on their NSAF values, which, again after subtracting all
mitochondrial proteins, left 710 proteins in the skeletal muscle
NE fraction (supplemental Table S3).
This protein set includes not only membrane proteins but
also many soluble proteins. Some of these soluble proteins
may have binding sites throughout the nucleus but nonethe-
less have relevant interactions at the NE. In contrast, the
subset of proteins harboring transmembrane spans (NETs) is
the most likely to be enriched at the NE and constitutes the
surest core NE components. This set of proteins include all 13
of the original well characterized NETs, which were ubiqui-
tously detected in our large scale analyses of nuclear enve-
lopes isolated from liver (26), blood (28), and now muscle;
these ubiquitous NETs were also recovered at high levels
(dNSAF values) and reproducibly in multiple analyses of mus-
cle NE (supplemental Fig. S2A and Table S5). An additional 28
liver NETs had been previously detected in liver NE data sets
(26), 14 of which have confirmed NE residence (supple-
mental Fig. S2B and Table S5). Another 109 proteins were
predicted to contain at least one transmembrane domain by
TMHMM v2.0 or membrane anchor by SignalP. Some of the
transmembrane proteins identified in the data sets were
known proteins that had not been detected previously at the
NE, many being ion transporters that likely function in mus-
cle SR. Others had no annotations at the time of data set
generation, and we selected 53 of these as putative novel
NETs, 24 of which were also detected in a concurrent pro-
teomics analysis of NEs from peripheral blood leukocytes
(Ref. 28; supplemental Fig. S2C and Table S5). Within the
“muscle-only” muscle NETs, one protein of high abundance
was detected in six of seven runs (TMEM38A), another group
of 11 proteins of lower abundance was detected in at least
two runs, whereas 21 proteins were detected only once and at
the lowest levels (supplemental Fig. S2D and Table S5). The
nuclear envelope targeting of over half of the proteins (48 of
94) plotted in supplemental Fig. S2 has been confirmed. In
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particular, 15 of the low abundance NETs have been directly
tested by us and by others (see below and supple-
mental Table S5) and confirmed at the NE.
Muscle-specific NETs—The identification of new NETs in
skeletal muscle that were not in previous liver, blood, and
neuroblastoma cell data sets (26–28) could reflect either their
preferential expression in muscle or differences in the sensi-
tivity of the mass spectrometers between the time of the
different studies. To distinguish between these possibilities, a
subset of novel putative rat skeletal muscle NETs was
searched for expression levels in the BioGPS transcriptome
database that compared relative expression for RNAs from
over 60 mouse tissues on microarrays (mouse was used
because very little rat transcriptome data were available) (29,
48). Although many NETs were widely expressed according to
the transcriptome data, others were preferentially expressed
in heart and/or skeletal muscle over other tissues (Fig. 3A). A
few of these were just 3–10-fold higher in the heart and/or
skeletal muscle than the median value for all other tissues, but
several reached levels greater than 100-fold over the median
value (Fig. 3A and Table II). Most of the eight putative NETs
shown were expressed at roughly background levels in liver
and bone marrow, explaining why they were not found in
previous liver (26) or leukocyte (28) NE data sets and further
reflecting tissue specificity in the NE proteome.
To confirm these results, qRT-PCR was performed on the
same eight muscle NETs over seven human tissues including
cardiac and skeletal muscle. Using GAPDH as a standard and
CKM as a positive control, all but TMX4 were more highly
expressed than in liver in at least one of the two muscle
tissues (Fig. 3B). The results did not precisely match the
BioGPS data for which there are many possible explanations,
but most of the NETs were preferentially expressed in muscle
over several other tissues in both systems.
The tissue specificity of NET expression based on the tran-
scriptome data was not always shared between species (Ta-
ble II). The BioGPS transcriptome database also compared
relative RNA expression levels for over 70 human tissues (29,
48). Some NETs like WFS1 and POPDC2 were highly ex-
pressed in heart muscle in both human and mouse systems.
However, GPR116 was very preferentially expressed in
mouse heart and skeletal muscle yet was expressed at the
median level in all human muscle groups (Table II). This may
indicate species differences as well as tissue differences in
the NE proteome.
Confirmation of NE Residence—To directly test NE resi-
dency for novel NETs as a measure of the validity of novel
protein identifications, 10 putative NETs from the skeletal
muscle data set were cloned as tagged fusions (GFP and/or
monomeric red fluorescent protein) and expressed in tissue
culture cells. Some were not expressed in the HT1080 cells
first used, but when a variety of different cell lines were
utilized, all 10 putative NETs were expressed and yielded a
discernible rim at the nuclear periphery (Fig. 4A). However,
FIG. 4. Confirmation of NE residence for NETs by targeting
tagged fusion proteins. A, NETs were tested as tagged fusions for
NE targeting, which is determined by their enrichment in a rim at the
limits of DNA staining. NET fusions are visualized in white in the left
panels and in red in the right panels, whereas DNA is visualized in
white in the right panels. NETs were sometimes expressed or targeted
better in certain cell types: all panels shown are U2OS osteosarcoma
cells except for TMEM38A in mouse C2C12 cells and TMEM70 and
CKAP4 in HeLa cells. All micrographs are on the same scale except
for CKAP4 with all scale bars at 10 m. B and C, inner versus outer
nuclear membrane targeting. Structured illumination microscopy can
distinguish proteins in the INM from those in the ONM when co-
stained with nuclear basket protein Nup153 and cytoplasmic filament
protein Nup358. B, an ONM NET or ER/ONM protein (red) should be
in the same plane with Nup358 (green) but should be external to
Nup153 (green), and this is observed for the control ER protein
Sec61 (upper schematic and images). Correspondingly, an INM NET
should be in the same plane as Nup153 and internal to Nup358 as is
observed for the control NET LAP2 (lower schematic and images). C,
all new NETs tested appeared in the same plane of the INM with
Nup153 and formed an internal ring to Nup358, indicating INM resi-
dence. Bars, 5 m.
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they were quite variable in the percentage of the protein
accumulating at the NE. For example, TMEM194 tended to
have a very crisp nuclear rim, whereas POPDC2 had higher
levels in the cytoplasm, although a rim could still be dis-
cerned. Those that had both NE and ER accumulation can be
explained by three possibilities. First, binding sites for the NET
at the NE might have become saturated due to overexpres-
sion, a phenomenon common among NETs. A corollary of this
possibility is that partner proteins involved in tethering the
NET in the NE are of low abundance in the cell lines used. This
FIG. 5. Antibody staining confirms novel NET identifications. A, Western blots testing antibodies generated to novel muscle NETs
TMEM38A, LOC203547, and POPDC2, control NET SUN2, and a NET previously identified in liver that appears to be much more abundant in
muscle, TMEM201/NET5. The correct size for each NET is indicated by an asterisk. B, comparison of the relative amounts of proteins in ER
(microsome) and NE fractions. Lamin A was used as a control for a NE-specific protein, whereas Calreticulin was used as a control for an ER
protein. Western blots of the two fractions similarly loaded for total protein were quantified on a LI-COR Odyssey imaging system, and the
percentage of the total signal between both microsome and NE lanes was plotted with NE signal in blue and microsome signal in yellow (three
repeats were averaged). The new muscle NETs were more enriched in the NE fraction than was the control NET SUN2. C, cryosections of rat
muscle stained with NET antibodies. NE staining was clearly observed for all NETs tested as determined by a rim around the DAPI-stained DNA.
Leg muscle is shown for TMEM38A, and heart is shown for the other two NETs. Bars, 10 m. D, antibody staining on pre-extracted cells. All
cells shown are C2C12 mouse myoblasts except in the case of TMEM201 where HeLa cells are shown. Cells were pre-extracted with detergent
(1% Triton X-100) to remove membranes and most soluble cytoplasmic material and then fixed and incubated with NET antibodies. A nuclear
rim staining was observed for the control NET SUN2 and all novel NETs tested. The resistance to detergent pre-extraction is consistent with
the INM localization indicated by OMX results in Fig. 4.
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is the possibility we consider most likely because of the high
degree of tissue specificity in expression of these NETs. Sec-
ond, the NET might normally have multiple cellular localiza-
tions as a recent proteomics study has suggested for nearly
40% of the mammalian proteome (58). Third, it is possible that
the GFP/red fluorescent protein fusion altered the NET protein
structure so that it is targeting aberrantly. In this latter case, it
is actually more likely that a reduction in affinity at an NE-
tethering site results in artifactual accumulation in the ER than
that the NE targeting is artifactual, although both are possible.
KLHL31 staining was highly filamentous and only sometimes
completely encircled the NE. High resolution deconvolved
images confirm its proximal association with the NE, but it
appeared in some cases of overexpression to concentrate in
membrane invaginations protruding into chromatin and in oth-
ers to form filaments that extended into the cytoplasm beyond
the NE.
The NE equally comprises INM and ONM, so NETs could
occur in one or the other subcompartment. Structured illumi-
nation microscopy (OMX) can distinguish INM from ONM
localization by co-staining for proteins from the NPC nuclear
basket (Nup153) or cytoplasmic filaments (Nup358) (59). The
NPC nuclear basket and cytoplasmic filaments both distend
more than 50 nm away from the NE, which itself is roughly 50
nm from the ONM to the INM. Therefore, the combined sep-
aration between NETs and these distal NPC components is
within the 100-nm-resolution limit of the OMX system. If a
NET is in the ONM, one would observe localization to the
same plane as Nup358 and some planar separation with
Nup153 (Fig. 4B, upper schematic), and this is what was
observed for the ONM control protein Sec61 (Fig. 4B, upper
image). The reverse should apply for an INM protein with
localization to the same plane as Nup153 and some planar
separation with Nup358 (Fig. 4B, lower schematic), and this is
what we observed for the INM control protein LAP2 (Fig. 4B,
image). Yellow co-localization is generally not observed in this
system because the OMX also resolves the 120-nm gaps in
the nuclear membrane where the NPCs are inserted from the
NETs in the membrane itself. Similarly to the control NET
LAP2, all the new skeletal muscle NETs tested here were
found to accumulate in the INM as both the NET (red) and
Nup153 (green) localized to the inner ring, whereas an inner
NET ring could be distinguished from an outer Nup358 ring
(Fig. 4C).
To test localization of endogenous protein, polyclonal anti-
bodies were generated to four novel NETs (TMEM38A,
POPDC2, LOC203547, and TMEM201). Antibodies were also
obtained for the control NET SUN2. Each antibody recognized
a protein of the correct size in immunoblots (Fig. 5A). Antibodies
against each NET were incubated with similar amounts of NE
and microsome preparations. Signals from the Western blots
were detected with fluorescent antibodies and quantified. The
total signal intensity from both NE and microsome bands were
measured, and the percentage of total signal for each was
plotted. Surprisingly, the control SUN2 had the highest percent-
age appearing in the microsome fraction (Fig. 5B). Thus, when
not overexpressed, these novel NETs are more exclusive to the
NE than one of the best characterized NETs.
POPDC2 and LOC203547 antibodies produced distinctive
nuclear rim staining on rat heart muscle cryosections (Fig.
5C). The nuclei were clearly visualized with DAPI, and the
antibody staining was concentrated in a crisp rim just sur-
rounding the nucleus. The TMEM38A antibodies produced
strong nuclear rim staining in rat leg skeletal muscle cryosec-
tions in addition to fainter staining in the SR (Fig. 5C). This is
consistent with supplemental data from a previous report on
this protein that introduced it as an SR protein (60). The
appearance of TMEM38A in the INM as well as the SR resem-
bles the well characterized NET Emerin that has been re-
ported in the cytoplasm of myotubes and interstitial discs of
heart tissue (55, 56, 61). Consistent with the immunofluores-
cence results, some peptides were obtained in the mass
spectrometry analysis of the SR fraction for TMEM38A,
Emerin, and SUN2 (supplemental Table S3).
Many previously characterized NETs resist a prefixation
extraction with 1% Triton X-100 and 400 mM KCl presumably
due to tight associations with the intermediate filament Lamin
polymer. The functioning antibodies enabled testing of this on
mouse C2C12 myoblast cells. C2C12 cells grown on cover-
slips were extracted with 1% Triton X-100 prior to fixation.
The antibodies concentrated in a rim around the DNA, con-
sistent with retention of these NETs after the detergent pre-
extraction and consistent with observations of INM targeting
by OMX. One of the NETs tested, LOC203547, had not been
FIG. 6. NE composition changes during muscle differentiation.
Expression levels of several muscle NETs were tested in both C2C12
(mouse) and RD (human) myoblast to myotube differentiation sys-
tems. RNA extracted from both untreated myoblast and chemically
differentiated myotube populations were subjected to RT-PCR for
each NET, and expression levels were quantified. The relative change
between myoblast and myotube populations was determined after
first normalizing values to the control peptidylprolyl isomerase A
(PPIA). Relative transcript levels for both human and mouse systems
are shown, and error bars indicate standard deviations between three
replicates for each differentiation system. Four NETs were induced
similarly to positive differentiation controls, MYOG and MYH1.
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cloned or tested by exogenous expression, bringing the num-
ber of new NETs with confirmed NE residence to 11. Another
of the NETs shown, TMEM201, was previously identified in
the liver data set as NET5 (26) but was tested here because it
had many more peptides in the skeletal muscle data set
(supplemental Table S3).
Several Muscle NETs Are Up-regulated during Muscle
Differentiation—Muscle-specific NETs could have functions
related to myogenic differentiation. Thus, expression levels
of several skeletal muscle NETs were analyzed in myogenic
differentiation systems where myoblast cell lines are grown
to confluency and then moved to reduced serum medium
containing pharmacological agents to induce differentiation.
The myoblasts then fuse to form multinucleate myotubes
with several characteristics of differentiated muscle. In both
human (RD; Ref. 62) and mouse (C2C12; Ref. 63, 64) sys-
tems, negative controls were unchanged, whereas
TMEM38A and KLHL31 were induced similarly to the posi-
tive controls, myogenin (MYOG) and myosin heavy chain
(MYH1) (Fig. 6). POPDC2 and TMEM161A were both up-
regulated only in the mouse system. The up-regulation of
certain NETs in myogenic differentiation is consistent with
their tissue-restricted expression patterns and the fact that
the antibodies yielded more distinctive nuclear rim staining
in skeletal and heart muscle cryosections than in cell lines.
Three Novel Skeletal Muscle NETs Appear to Associate
with the Cytoskeleton—Nesprins 1 and 2 in the ONM bind to
the actin cytoskeleton and contribute to nuclear positioning
(17), whereas Nesprin 3, originally identified by proteomics
of liver NEs (NET53; Ref. 26), binds plectin and thus pre-
sumably connects the NE to the intermediate filament cy-
toskeleton (24). These ONM NETs are also connected to the
INM SUN proteins that in turn bind Lamins, hence connect-
ing the cytoskeleton to the nucleoskeleton (15). Thus, NETs
in both the ONM and INM are involved in connecting cy-
toskeletal filaments to the nucleoskeleton. The importance
of such connections is illustrated by the recent discovery
that mutations in Nesprins 1 and 2 (23) also cause EDMD.
FIG. 7. Muscle NET alignment with
microtubules. U2OS cells expressing
various NET-GFP fusions were fixed and
stained for microtubules. Sections from
deconvolved images are shown for a fo-
cal plane at the upper nuclear surface.
DAPI staining for DNA is in blue, micro-
tubules are in green, and the NET is in
red. In the right columns, the microtu-
bules or NET are shown in grayscale.
Microtubule filaments are observed
crossing the nuclear surface in the SUN2
control-transfected cell, but the SUN2
staining on the surface is spotty, con-
sistent with previous reports. The same
was observed for RHBDD1 and most
muscle NETs tested; however, KLHL31,
which had a more filamentous appear-
ance in Fig. 4, exhibited filaments also
on the nuclear surface that partly
tracked with the microtubule filaments
(note both grayscale images for each
and some yellow co-localization in the
merge panel). TMEM214, although con-
sistently yielding a much crisper and
continuous rim at the nuclear periphery,
also exhibited filamentous accumulation
at the nuclear surface that exhibited
even more overlap with microtubules.
Scale bars, 10 m.
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NETs connecting microtubules to the nucleus have not
previously been identified, but it is clear that microtubules
have some interactions with the NE because they associate
with the NE prior to NE disassembly in mitosis (65), and
NET5/TMEM201/Samp1 associates with both the centro-
some and the mitotic spindle (30, 66). As muscle cells have
many unique cytoskeletal features, the novel NETs from skel-
etal muscle were screened for effects indicating any associ-
ations with microtubules.
The NETs were overexpressed in U2OS cells and co-visu-
alized with the microtubule cytoskeleton. Overexpression of
most NETs yielded no visible alterations in microtubule orga-
nization. However, cell sections at the upper surface of the
nucleus revealed a filamentous distribution for KLHL31 and
TMEM214 (Fig. 7) in nearly all transfected cells. This strongly
contrasted with the typical punctate distribution of NETs at
the nuclear surface (SUN2 and RHBDD1 shown). Overlaying
the NET and microtubule staining patterns in these sections
for KLHL31 and TMEM214 revealed significant co-localiza-
tion; however, the percentage of microtubules visible at the
nuclear surface that tracked with the NETs was highly variable
from cell to cell. The upper cell for TMEM214 shows also how
some of the overexpressed NET distributed in the ER also
tracked with the microtubules in the cytoplasm and the lack of
a clear microtubule-organizing center. The lower cell shows a
different defect with two microtubule-organizing centers at
the center of the nuclear surface.
Observations of NPC-associated proteins and the NE
Lamin proteins on the mitotic spindle (e.g. Lamin B, Importin
, and Ran; Refs. 67–69) provided the first evidence that NE
proteins have separate roles in mitosis. A more recent study
showed that NET5/TMEM201/Samp1 associates with the
base of the mitotic spindle in mitosis (30). During mitosis,
many NETs are redistributed into small vesicles that spread
throughout the cell except from the spindle area. This pattern
was observed for most NETs with SUN2 and RHBDD1 shown
as examples (Fig. 8). In contrast, TMEM214 exhibited an
increased concentration by the spindle base in most cells,
although it was excluded from the spindle poles themselves
(Fig. 8, upper right TMEM214 panel). Some cells exhibited an
even more striking microtubule association with clear co-
localization throughout the length of many spindle microtu-
bules (Fig. 8, lower TMEM214 panels). KLHL31 was distrib-
uted differently in mitosis, associating more with the mitotic
chromosomes than with microtubules. WFS1, although not
tracking with microtubules in interphase, exhibited a distribu-
tion similar to that of TMEM214 with a concentration around
the base of the spindle in mitosis (Fig. 8, bottom panels).
DISCUSSION
This analysis of the skeletal muscle NE proteome identified
many new NE-associated proteins and NETs not identified in
earlier studies of liver and neuroblastoma NEs (26, 27) or a
more recent study of blood NEs (28). Moreover, some of these
FIG. 8. Partial NET-microtubule associations are also observed
in mitosis. In mitosis, the NE breaks down, and several NPC proteins
and Lamins have previously been reported to partly assemble on the
mitotic spindle. The negative control SUN2 and the new muscle-
specific NET RHBDD1 were generally distributed throughout the mi-
totic cell but excluded from the spindle (white arrowheads point to
one of the spindles in each cell). No particular accumulation or
change in the NET distribution was observed with respect to the
mitotic spindle. As a positive control, TMEM201 (NET5/Samp1) is
shown as it has previously been shown to associate with the spindle.
TMEM214 exhibited in most cells a strong accumulation at the base
of the spindles close to the poles but was excluded from the poles
themselves. In other cells, the distribution was even more focused on
the spindle itself with significant co-localization with the microtubules.
A third muscle NET, WFS1, consistently yielded the first phenotype of
TMEM214; however, in many cases, an even more pronounced ac-
cumulation surrounding the spindle poles was observed. One spindle
pole in each cell (except the prophase TMEM214 cell) is marked by an
arrowhead. Scale bar, 10 m.
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proteins had very restricted tissue expression and were spe-
cifically up-regulated in myogenic differentiation systems.
Thus, each tissue likely has a different combination of proteins
in its NE proteome. That some of these more tissue-restricted
NETs track with the microtubule cytoskeleton has the poten-
tial to explain some of the tissue specificity of NE disease
phenotypes. The three favored hypotheses to explain how NE
protein mutation can yield pathology are altered expression of
genes regulated from the nuclear periphery, mechanical in-
stability from disruption of lamina-cytoskeleton interactions,
and disabling of the cell cycle/stem cell maintenance (6, 7).
That NET-microtubule associations indicated here appear to
occur in both interphase and mitosis provides potential mech-
anisms toward both mechanical instability and cell cycle reg-
ulation. That some of these proteins are tissue-restricted pro-
vides a potential explanation for the tissue preferences in NE
disease pathologies.
Much additional work will be required to determine such
disease links and whether associations are direct or indirect.
Nonetheless, the tracking of TMEM214 and KLHL31 with
microtubules on the nuclear surface is both striking and a
novel finding among all NETs identified thus far. The associ-
ation of TMEM214 and WFS1 at the base of the spindles in
mitosis resembles that observed for NET5/TMEM201/Samp1
(30). This finding followed observations that Ima1, the yeast
homolog of this NET, is involved in connecting the NE to the
centrosome (66). Thus, the potential link to cell cycle regula-
tion is even stronger.
The idea of more tissue-specific NETs participating in pro-
tein complexes at the NE whose disruption could lead to more
muscle-specific pathologies makes sense (70). It is hard oth-
erwise to explain how mutations in ubiquitous proteins like
Lamin A, Emerin, or the Nesprin proteins could result in tis-
sue-specific pathologies (18–23). Interestingly, WFS1 has al-
ready been linked to three disorders, although the function of
the protein remains obscure (71–73). These initial successes
in identifying tissue-specific NETs that have links to disease
indicate the importance of investigating the NE proteome in all
tissues linked to disease.
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